article thumbnail

Slideshow: Assessing the COVID-19 Pandemic After its 2020 Peak

Drug Topics

Four posters presented at the American Pharmacists Association Annual Meeting and Exposition explored how individuals and health care providers have been handling the COVID-19 pandemic.

276
276
article thumbnail

Health Care Spending Has Shot Back Up to Pre-Pandemic Levels

Drug Topics

The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.

Insurance 452
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

For the First Time Medicaid Net Drug Spending Hits Double-Digits

Drug Topics

Spending on specialty drugs fueled a 11% increase in Medicaid drug spending from 2020 to 2021, says Magellan's seventh annual Medicaid Pharmacy Trend Report.

503
503
article thumbnail

CVS Health Survey Reports Increases in Mental Health Concerns Since 2020

Pharmacy Times

The survey reported that approximately 65% of participants were concerned about their mental health, which is a 15% increase since 2020.

139
139
article thumbnail

Type 2 Diabetes in Young Patients Spiked in Year 1 of COVID-19 Pandemic

Drug Topics

Using electronic medical record data from 2018-2020 obtained from 24 medical centers across the US, including Johns Hopkins, University of Colorado, and Mayo Clinic institutions, a new study suggests rates of youth onset type 2 diabetes increased 77% during the first year of the pandemic.

article thumbnail

Cardiovascular Mortality Rates Increased From 2020 to 2022, Correlating With Pandemic

Pharmacy Times

Investigators also found that the mortality rates for cardiovascular disease from 2020 to 2022 reversed the improvements of reduced mortalities in the preceding decades.

139
139
article thumbnail

Federal Bill Reintroduced to Strengthen Pharmaceutical Supply Chain

Drug Topics

Senators Elizabeth Warren and Tina Smith have reintroduced the Pharmaceutical Supply Chain Defense and Enhancement Act originally established in 2020.

247
247